These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16547384)

  • 61. Coagulation inhibitors (protein C and antithrombin III) in the preterm infant during the first month of life.
    De Mattia D; Mautone A; Montagna O; Giordano P; Altomare M; Del Vecchio GC; Schettini F
    Acta Paediatr Scand; 1990 Dec; 79(12):1235-6. PubMed ID: 2085112
    [No Abstract]   [Full Text] [Related]  

  • 62. A study of interferon-gamma and interleukin-2 production in premature neonates and neonates with intrauterine growth retardation.
    Saito S; Kato Y; Maruyama M; Ichijo M
    Am J Reprod Immunol; 1992; 27(1-2):63-8. PubMed ID: 1610490
    [TBL] [Abstract][Full Text] [Related]  

  • 63. From hyperinsulinaemic hypoglycaemia to ketotic hypoglycaemia: the range of glucose abnormalities in patients born with intrauterine growth retardation.
    Kochar IS; Hussain K
    Eur J Pediatr; 2007 Oct; 166(10):1003-7. PubMed ID: 17177070
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Peripheral blood leucocyte zinc depletion in babies with intrauterine growth retardation.
    Meadows N; Ruse W; Keeling PW; Scopes JW; Thompson RP
    Arch Dis Child; 1983 Oct; 58(10):807-9. PubMed ID: 6639130
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of intrauterine growth restriction on sleep and the cardiovascular system: The use of melatonin as a potential therapy?
    Yiallourou SR; Wallace EM; Miller SL; Horne RS
    Sleep Med Rev; 2016 Apr; 26():64-73. PubMed ID: 26140865
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Intrauterine growth restriction and zinc concentrations in term infants during the first month of life.
    Yamada RT; Leone CR
    J Am Coll Nutr; 2008 Aug; 27(4):485-91. PubMed ID: 18978168
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Transitory hypothermia as early prognostic factor in term newborns with intrauterine growth retardation].
    Lazić-Mitrović T; Djukić M; Cutura N; Andjelić S; Curković A; Soldo V; Radlović N
    Srp Arh Celok Lek; 2010; 138(9-10):604-8. PubMed ID: 21180090
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Blood glucose in newborn infants, at term premature infants and infants with fetal growth retardation].
    Rokicki W
    Ginekol Pol; 1983 Feb; 54(2):99-103. PubMed ID: 6683695
    [No Abstract]   [Full Text] [Related]  

  • 69. [Peculiarity of cyclic sleep organization and production of melatonin in intrauterine growth retardation's newborns].
    Evsiukova II; Koval'chuk-Kovalevskaia OV; Maslianiuk NA; Dodkhoev DS
    Fiziol Cheloveka; 2013; 39(6):63-71. PubMed ID: 25509173
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Free carnitine concentrations in cord blood in preterm and full-term infants with intrauterine growth retardation.
    Akisu M; Bekler C; Yalaz M; Hüseyinov A; Kültürsay N
    Pediatr Int; 2001 Feb; 43(1):107-8. PubMed ID: 11208015
    [No Abstract]   [Full Text] [Related]  

  • 71. Antithrombin III in fetuses and newborn children.
    Latin V; Janković D; Cervar M; Bernt T; Fudurić I
    Acta Obstet Gynecol Scand; 1994 Jan; 73(1):74-5. PubMed ID: 8304033
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Plasma protein C and antithrombin III levels in polycythemic newborns.
    Yurdakök K; Oran O; Tekinalp G; Dündar S; Yurdakök M
    Pediatr Hematol Oncol; 1989; 6(1):59-61. PubMed ID: 2641701
    [No Abstract]   [Full Text] [Related]  

  • 73. Perinatal systemic inflammatory responses of growth-restricted preterm newborns.
    McElrath TF; Allred EN; Van Marter L; Fichorova RN; Leviton A;
    Acta Paediatr; 2013 Oct; 102(10):e439-42. PubMed ID: 23819682
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Changes in body temperature and urinary cortisol after routine immunization in babies with intrauterine growth retardation.
    Jackson JA; Wailoo MP; Petersen SA; Thompson JR; Davies T
    Acta Paediatr; 2001 Oct; 90(10):1186-9. PubMed ID: 11697433
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Protein C activity and antigen in premature and fullterm newborn infants.
    Bennhagen R; Holmberg L
    Acta Paediatr Scand; 1989 Jan; 78(1):34-9. PubMed ID: 2919522
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Blood fibrinolytic activity in neonates: effect of period of gestation, birth weight, anoxia and sepsis.
    Kolindewala JK; Das BK; Dube RK; Dube B; Bhargava V
    Indian Pediatr; 1987 Nov; 24(11):1029-33. PubMed ID: 3450641
    [No Abstract]   [Full Text] [Related]  

  • 77. [On the erythrocytic arginase activity in the full-term newborn infant and in the premature infant].
    MARTUCCI E; MIRAGLIA M; ROLANDO P
    Pediatria (Napoli); 1961; 69():948-53. PubMed ID: 14470614
    [No Abstract]   [Full Text] [Related]  

  • 78. [Circulating granulomonocytic precursor cells and phenotype of peripheral blood monocytes in premature infants].
    Torubarova NA; Koshel' IV; Mitiurova LB; Bragina NK; Chung N
    Gematol Transfuziol; 1989 Sep; 34(9):40-4. PubMed ID: 2583461
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Clinico-hemostatic features in premature infants with hypertensive hydrocephalic syndrome].
    Litvinova AM; Stotskaia GE
    Pediatriia; 1991; (5):40-3. PubMed ID: 1866235
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antithrombin in infancy and childhood.
    Catrine A; Nilsson T
    Acta Paediatr Scand; 1975 Jul; 64(4):624-8. PubMed ID: 808091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.